Results 181 to 190 of about 28,830 (248)

Proprotein Convertase Subtilisin/Kexin Type 7 [PDF]

, 2020
openaire   +1 more source

Proprotein convertase subtilisin/kexin type 9: a promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention. [PDF]

Front Med (Lausanne)
Rottura M, Barbieri MA, Siniscalchi C, Di Micco P, Drago SFA, Gigliotti De Fazio M, Cicero AFG, Fogacci F, Armentaro G, Sciacqua A, Arcoraci V, Irrera N, Imbalzano E.   +12 more
europepmc   +1 more source

Efficacy and safety of different proprotein convertase subtilisin/kexin type 9 inhibitors in the general population and solid organ transplant recipients: a network meta-analysis. [PDF]

Front Pharmacol
Luo B, Sun Z, Luo H.
europepmc   +1 more source

Multimodal assessment of treatment with proprotein convertase subtilisin/kexin type 9 inhibitors combined with statins for regulating coronary artery plaque regression in patients with chronic/acute coronary syndrome: A meta-analysis. [PDF]

J Int Med Res
Yuan D, Cheng T, Cao Z, Wang F, Wang Y.
europepmc   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 [PDF]

, 2020
openaire   +1 more source

The correlation between proprotein convertase subtilisin/kexin type 9 and adiponectin in the progression from prediabetes to type 2 diabetes mellitus. [PDF]

Sci Rep
Gu JX, Wang K, Zhang AM, Yin Y, Li SS, Zhang N, Qin L, Wang CY, Pei L, Jia M, Su M.   +10 more
europepmc   +1 more source

Correction: Ascorbic acid enhances low-density lipoprotein receptor expression by suppressing proprotein convertase subtilisin/kexin 9 expression. [PDF]

J Biol Chem
Wang D, Yang X, Chen Y, Gong K, Yu M, Gao Y, Wu X, Hu H, Liao C, Han J, Duan Y.   +10 more
europepmc   +1 more source

The proprotein convertase FURIN is a novel aneurysm predisposition gene impairing TGF-β signalling. [PDF]

Cardiovasc Res
He Z, IJpma AS, Vreeken D, Heijsman D, Rosier K, Verhagen HJM, de Bruin JL, Brüggenwirth HT, Roos-Hesselink JW, Bekkers JA, Huylebroeck DFE, van Beusekom HMM, Creemers JWM, Majoor-Krakauer D.   +13 more
europepmc   +1 more source

Successful use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Hypertriglyceridemia-induced Acute Pancreatitis: A Case Report. [PDF]

Curr Cardiol Rev
Qi R, Liu H, Li X, Chen M.
europepmc   +1 more source

Association between statin discontinuation after proprotein convertase subtilisin/kexin type 9 inhibitor initiation and subsequent atherosclerotic cardiovascular disease events. [PDF]

J Manag Care Spec Pharm
Peasah SK, Lee T, Do D, Huang Y, Inneh A, Patel U, Aiyer AN, Good CB.   +7 more
europepmc   +1 more source